[1]
N. J. Sweiss, “Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 31, no. 1, pp. 46–54, Apr. 2014, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/2943